Lausanne Trialogue Paradigm - Brief: A Family Model for Child Mental Health in a Community Setting (LTP-B)

July 11, 2022 updated by: Heather Prime, York University

Lausanne Trialogue Paradigm - Brief: A Family Systems Model to Address Child Mental Health in a Community Mental Health Setting

The current study is a feasibility pilot of the Lausanne Trialogue Play paradigm Intervention - Brief (LTP-Brief), a family systems therapy implemented in a community mental health setting. We will study the ultrabrief, virtual therapy to assess the feasibility of a future pilot RCT. Feasibility metrics include resource, scientific, and management considerations, as well as an examination of pre-post change in future child and family outcomes of interest.

Study Overview

Detailed Description

COVID-19 represents an acute crisis to children's mental health, with potential for long-term consequences. There is evidence for elevated mental health symptomatology in children since the start of the pandemic, with the emergence of stress-related disorders and the exacerbation of pre-existing disorders. Indeed, the pandemic has had detrimental effects on family life due to widespread job loss and financial insecurity, and increases to parental psychological distress, mental illness, and substance use. Social consequences of COVID-19 are expected to have cascading negative effects on child mental health symptoms. Thus, a COVID-19 family recovery program is critically needed, both during and after the pandemic, to manage the current mental health crisis in children and create cascading and sustainable effects for lifelong physical and mental health. The main goal of the the current study is to investigate feasibility of a future pilot and/or main RCT of a brief, virtual mental health treatment program for children and families designed to optimize reach of services. Specifically, the Lausanne Trialogue Play paradigm assessment is a semi-structured assessment of whole family interactions, with emphasis on the co-parenting relationship, which has been used extensively in research settings for assessment and consultative purposes. The current study will assess the feasibility of using the LTP in an assessment-as-treatment model. This brief treatment program, called the LTP-Brief intervention (LTP-B) will consist of a family play assessment (including an LTP assessment) with video feedback to caregivers as a method for promoting change in family interaction patterns. By targeting change across the family system, rather than focusing on specific child mental health symptoms directly, the model addresses upheaval of family life during COVID-19 and has potential to create sustainable improvements in family well-being within a short period of time.

Study Type

Interventional

Enrollment (Anticipated)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Diane Philipps, PhD

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M3J 1P3
        • Recruiting
        • York University
        • Contact:
        • Principal Investigator:
          • Heather Prime, PhD
        • Principal Investigator:
          • Diane Philipps, PhD
        • Principal Investigator:
          • Joelle Darwiche, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 second to 15 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The sample will comprise of families referred to the outpatient mental health services at Sick Kids Center for Community Mental Health (SKCCMH), a non-profit children's mental health treatment centre in Toronto, ON, Canada.
  • Participants will include children ages 0 months to 15.11 years old, and their caregivers, though the majority will fall in the range of 3- to 14-years-old.
  • The first 25 families to be referred to the LTP-B service and who agree to participate in research will be included.

Exclusion Criteria:

  • No exclusion criteria beyond what is standard for the clinical service at SKCCMH.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: LTP-B Intervention
Families will take part in an online semi-structured assessment and video feedback paradigm of family interactions, with an emphasis on co-parenting and parent-child relations.
The brief treatment program will consist of an LTP family assessment with video feedback to caregivers to address family interaction patterns and child mental health. Families will participate in four sessions conducted online using the Zoom for Healthcare platform. In the first session, families will engage in a family assessment in different groupings that will be recoded on zoom and used later in the treatment. In the second session, taking place one week later, families will take part in a mini assessment to learn more about the difficulties of the child. In the third session, the clinical team will share videos of the family assessment to the parents and discuss the families strengths, concerns, and goals for moving forward. In the fourth session, taking place one month after the third session, families will participate in a check-in session, debriefing the family assessment.
Other Names:
  • LTP-B

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
COVID-19-related Family Stressors
Time Frame: Time 0, 3
Descriptive (no criterion for success): Family Stressor Scale. Minimum score=16, maximum score=48. Higher scores correspond to worse outcomes.
Time 0, 3
COVID-19-related Family Positive Adaptation
Time Frame: Time 0, 3
Descriptive (no criterion for success): COVID-19 Family Positive Adaptation Scale. Minimum score=14, maximum score=42. Higher scores correspond to better outcomes.
Time 0, 3
Therapeutic Alliance
Time Frame: Time 1, 2, 3, 5
Descriptive (no criterion for success): Working Alliance Inventory-Short Revised (WAI-SR). Minimum score=12, maximum score=60. Higher scores correspond to better outcomes.
Time 1, 2, 3, 5
Form Research-Clinical Partnership (1) - Clinical-Research Meetings
Time Frame: Time -1 to end of study
Criterion for success: Meet once monthly throughout the course of the study.
Time -1 to end of study
Form Research-Clinical Partnership (2) - Protocol Development - a
Time Frame: Time -1
Criterion for success: Administrative approval from SKCCMH for study (via approval of ethics approval).
Time -1
Form Research-Clinical Partnership (3) - Protocol Development - b
Time Frame: Time -1
Criterion for success: Submission of protocol for registration to clinicaltrials.gov and/or journal publications.
Time -1
Research-Clinical Communication (1) - Clients Referred to LTP-B
Time Frame: Time -1
Criterion for success: 95% of clients referred to LTP-B to be asked permission to be contacted by the research team.
Time -1
Research-Clinical Communication (2) - Clients Transferred to Research Team
Time Frame: Time -1
Criterion for success: 95% of clients that agree to research are transferred to the research team for contact.
Time -1
Research-Clinical Communication (3) - Clinical Visits Shared
Time Frame: Time -1 to end of study
Criterion for success: 95% of participants' scheduled clinical visits to be shared with the research team.
Time -1 to end of study
Research-Clinical Communication (4) - Videos Shared
Time Frame: Time 1, 2, 3
Criterion for success: 95% of participant videos (previously consented) to be successfully shared with the research team.
Time 1, 2, 3
Clinical Service Flow (1) - Clients Referred
Time Frame: Time -1
Criterion for success: 3 families to be referred to the LTP-B per month.
Time -1
Clinical Service Flow (2) - Service Provision
Time Frame: Time -1
Criterion for success: 2 families to be seen by the LTP-B team per month.
Time -1
Participant Recruitment (1) - Agree to Research Contact
Time Frame: Time -1
Criterion for success: 90% of clients referred to LTP-B to agree to be contacted for purposes of research.
Time -1
Participant Recruitment (2) - Participants Enrolled
Time Frame: Time -1
Criterion for success: 90% of clients participating in LTP-B to enroll in the research study.
Time -1
Participant Recruitment (3) Families Enrolled Per Month
Time Frame: Time -1
Criterion for success: 1.8 families enrolled per month.
Time -1
Adherence to Intervention
Time Frame: Times 1, 2, 3
Criterion for success: 90% of participants to complete all three main LTP-B sessions (Family assessment, videofeedback, check in)
Times 1, 2, 3
Retention: Post-Intervention
Time Frame: Time 3
Criterion for success: 90% of participants to remain in study until the end of post-intervention assessment.
Time 3
Retention: Follow-Up
Time Frame: Time 4
Criterion for success: 80% of participants to remain in study until the end of follow-up assessment.
Time 4
Retention: Brief Surveys
Time Frame: Time 1, 2, 5
Criterion for success: 80% of participants to complete all brief surveys.
Time 1, 2, 5
Acceptability
Time Frame: Time 3, 4
Criterion for success: 80 % of participants reporting at least "agree" on indicators of attitude, burden, perceived effectiveness, and ethicality on an Implementation Acceptability Scale. Minimum score=7, maximum scores=35. Higher scores correspond to better outcomes.
Time 3, 4
Descriptive (no criterion for success): Behavioral Coding of Family Interactions (Frascarolo et al., 2018)
Time Frame: Week 1
Family interactions will be behaviourally coded by trained coders based on the LTP Assessments (initial family assessment), using previously validated approaches (e.g., Frasarolo et al., 2018).
Week 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brief Dyadic Adjustment
Time Frame: Time 0, 1, 2, 3, 4, 5
Using the Brief Dyadic Adjustment Scale (DAS-4). Minimum score= 0, maximum score=21. Higher scores correspond to better outcomes.
Time 0, 1, 2, 3, 4, 5
Coparenting Relationship Quality
Time Frame: Time 0, 3, 4
Using the Brief Coparenting Relationship Scale (Feinberg et al., 2012). Minimum score=0, maximum score=84. Higher scores correspond to better outcomes.
Time 0, 3, 4
Brief Coparenting Relationship Quality
Time Frame: Time 1, 2, 5
Using the Subset of Brief Coparenting Relationship Quality Scale (Feinberg et al., 2012). Minimum score=0, maximum score=36. Higher scores correspond to better outcomes.
Time 1, 2, 5
Parent-Child Positivity
Time Frame: Time 0, 3, 4
Using the 5-item parent-reported positivity subscale of the Parenting Practices Scale. Minimum score=5, maximum score=25. Higher scores correspond to better outcomes.
Time 0, 3, 4
Parent-Child Negativity
Time Frame: Time 0, 3, 4
Using the 5-item parent-reported negativity subscale of the Parenting Practices Scale. Minimum score=5, maximum score=25. Higher scores correspond to worse outcomes.
Time 0, 3, 4
Sibling Relations
Time Frame: Time 0, 3, 4
Using Parental Expectations and Perceptions of Children's Sibling Relationship Questionnaire (PEPC-SRQ). Minimum score=8 , maximum score=40. Higher scores correspond to better outcomes.
Time 0, 3, 4
Whole Family Functioning
Time Frame: Time 0, 3, 4
Using 6-item Family Assessment Device (FAD). Minimum score=5, maximum score=20. Higher scores correspond to worse outcomes.
Time 0, 3, 4
Parent Mental Health
Time Frame: Time 0, 3, 4
Using the Kessler Psychological Distress Scale (K10). Minimum score=10, maximum score=50. Higher scores correspond to worse outcomes.
Time 0, 3, 4
Brief Parent Mental Health
Time Frame: Time 1, 2, 5
Using the Kessler Psychological Distress Scale (K6). Minimum score=6, maximum score=30. Higher scores correspond to worse outcomes.
Time 1, 2, 5
Child Emotional and Behavioural Problems (1) - (Children Ages 18 months to 3 years 11 months)
Time Frame: Time 0, 3, 4

Scores will be standardized within each age group and used as a single outcome variable.

The Preschool Pediatric Symptom Checklist (PPSC-17): Minimum score=0, maximum score=36. Higher scores correspond to worse outcomes.

Time 0, 3, 4
Child Emotional and Behavioural Problems (2) - (Children Ages 4 to 18 years)
Time Frame: Time 0, 3, 4

Scores will be standardized within each age group and used as a single outcome variable.

The Pediatric Symptom Checklist (PSC-17). Minimum score=0, maximum score=34. Higher scores correspond to worse outcomes.

Time 0, 3, 4
Examine Therapy Sessions
Time Frame: Weeks 1, 2, 3
Examine content and process of all therapy sessions (including therapist and client behaviours) qualitatively for a select number of 'successful' and 'unsuccessful' cases, using a pragmatic case-series analysis (e.g., Liekmeier et al., 2021)
Weeks 1, 2, 3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Heather Prime, PhD, York University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2022

Primary Completion (Anticipated)

September 1, 2023

Study Completion (Anticipated)

September 1, 2023

Study Registration Dates

First Submitted

March 22, 2022

First Submitted That Met QC Criteria

April 29, 2022

First Posted (Actual)

May 2, 2022

Study Record Updates

Last Update Posted (Actual)

July 12, 2022

Last Update Submitted That Met QC Criteria

July 11, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parent-Child Relations

Clinical Trials on Lausanne Trialogue Play Brief

3
Subscribe